Super disintegrant for rapid tablet disintegration and drug release
Provides rapid and complete tablet disintegration for immediate drug release and enhanced bioavailability.
Maintains structural integrity while providing excellent swelling properties for effective disintegration.
Excellent chemical stability and compatibility with various active pharmaceutical ingredients.
Effective at low concentrations (1-5%), allowing for more active ingredient in formulations.
Parameter | Specification | Test Method |
---|---|---|
Appearance | White to off-white, free-flowing powder | Visual |
Identification | Complies with USP/EP standards | IR Spectroscopy |
pH (1% aqueous dispersion) | 5.0 - 8.0 | USP <711> |
Loss on Drying | ≤ 5.0% | USP <731> |
Residue on Ignition | ≤ 0.1% | USP <281> |
Heavy Metals | ≤ 10 ppm | USP <231> |
Nitrogen Content | 11.5 - 12.8% | USP <461> |
Particle Size Distribution | ≥ 95% through 100 mesh | USP <786> |
Bulk Density | 0.3 - 0.6 g/mL | USP <616> |
Tapped Density | 0.4 - 0.8 g/mL | USP <616> |
Microbial Limits | Total Aerobic Count: ≤ 1000 CFU/g Yeast & Mold: ≤ 100 CFU/g |
USP <61> |
Primary application as super disintegrant for rapid drug release and enhanced bioavailability.
Used in capsule formulations to improve drug dissolution and release characteristics.
Enhances disintegration in chewable formulations for improved palatability and drug release.
Ideal for ODT formulations requiring rapid disintegration in the oral cavity.
Suitable for direct compression processes with excellent flow and compaction properties.
Compatible with wet granulation processes for improved tablet properties.
Our Crospovidone (XL-10) meets the highest international pharmaceutical standards and regulatory requirements.
United States Pharmacopeia
European Pharmacopoeia
Japanese Pharmacopoeia
Indian Pharmacopoeia
British Pharmacopoeia
Contact us today for quotes, samples, or technical support